Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 4/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.48 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9528716 | 1.00 | LOXL2 (0.59) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL40826 | 0.89 | HSPB1 (0.58) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL28148788 | 0.83 | LOXL2 (0.55) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL27765240 | 0.83 | LOXL2 (0.61) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL27574845 | 0.83 | LOXL2 (0.55) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL3633600 | 0.83 | LOXL2 (0.55) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL7090996 | 0.83 | LOXL2 (0.55) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL28258180 | 0.83 | LOXL2 (0.55) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL1169849 | 0.83 | LOXL2 (0.55) | LOXL2TSHRIDO1CYP2C19CYP1A2 | |
| SCHEMBL27943219 | 0.82 | IDO1 (0.50) | LOXL2TSHRIDO1CYP2C19CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 579 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215467-A1 | L-THREONINE TRANSALDOLASES AND USES THEREOF | UNIVERSITY OF DELAWARE (US) | 2025-07-03 | — | — | US | claimed |
| WO-2023178318-A2 | L-THREONINE TRANSALDOLASES AND USES THEREOF | KUNJAPUR ADITYA (US) | 2023-09-21 | — | — | WO | claimed |
| CN-109651290-B | Preparation method of mirabegron | 安徽省庆云医药股份有限公司 | 2022-04-01 | — | — | CN | claimed |
| CN-109651290-A | A kind of preparation method of Mirabegron | 安徽省庆云医药股份有限公司 | 2019-04-19 | — | — | CN | claimed |
| WO-2018229261-A1 | COMBINATION MEDICAMENT COMPRISING A PRODRUG AND INHALABLE CATALYST | ETH Zürich (CH) | 2018-12-20 | — | — | WO | claimed |
| CN-103265457-B | A kind of synthetic method of (R)-4-aminophenethyl-(2-hydroxyl-2-styroyl)-t-butyl carbamate | SUZHOU UUGENE BIOPHARMA CO., LTD. (CN) | 2015-08-19 | — | — | CN | claimed |
| CN-103232368-B | A kind of synthetic method of (R)-4-nitrophenethyl-(2-hydroxyl-2-styroyl)-t-butyl carbamate | SUZHOU UUGENE BIOPHARMA CO., LTD. (CN) | 2015-08-12 | — | — | CN | claimed |
| CN-103265457-A | (R)-4-amino phenethyl-(2-hydroxy-2-phenylethyl)-tert-butyl carbamate synthesis method | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-08-28 | — | — | CN | claimed |
| CN-103232368-A | Synthesizing method of (R)-4-nitrophenethyl-(2-hydroxy-2-phenylethyl)-tert-butyl carbamate | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-08-07 | — | — | CN | claimed |
| CN-103193658-A | Synthesis method of (R)-2-p-nitrobenzene ethylamine-1-phenethyl alcohol and salt thereof | SUZHOU UUGENE BIOPHARMA CO LTD | 2013-07-10 | — | — | CN | claimed |
| US-5656753-A | 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them | AMERICAN CYANAMID COMPANY (US) | 1997-08-12 | — | — | US | claimed |
| WO-1991018861-A1 | 2-(HYDROXYMETHYL) ACRYLATE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1991-12-12 | — | — | WO | claimed |
| EP-4659809-A2 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | Regeneron Pharmaceuticals, Inc. (US) | 2025-12-10 | — | — | EP | disclosed |
| EP-3538539-B1 | STEROIDS AND PROTEIN-CONJUGATES THEREOF | REGENERON PHARMA (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12377159-B2 | Steroids and protein-conjugates thereof | REGENERON PHARMACEUTICALS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250215467-A1 | L-THREONINE TRANSALDOLASES AND USES THEREOF | UNIVERSITY OF DELAWARE (US) | 2025-07-03 | — | — | US | disclosed |
| US-4364865-A | ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1982-12-21 | — | — | US | disclosed |
| US-4191808-A | DIPEPTIDE CONTAINING PROLINE AND A PHOTOMETRICALLY DETECTABLE NITROANILINE, PHENYLAZOANILINE OR PHENYLAZONAPHTHYLAMINE GROUP | AJINOMOTO CO., INC. (JP) | 1980-03-04 | — | — | US | disclosed |
| US-4119620-A | Novel dipeptide derivatives, salts thereof, and method of measuring enzyme activity | AJINOMOTO CO., INC. (JP) | 1978-10-10 | — | — | US | disclosed |
| US-4070477-A | PENICILLINS | CIBA-GEIGY CORPORATION (US) | 1978-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12377159-B2 | Steroids and protein-conjugates thereof | SERPINA6, NR3C1, NR3C2 | LOXL2 2310/4885TSHR 809/4885IDO1 4679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.